Silence Therapeutics (SLN) Amortizatization of Intangibles (2020 - 2026)
Silence Therapeutics recorded quarterly Amortizatization of Intangibles of $34000.0 in Q1 2026, down 5.56% quarter-over-quarter from $36000.0 in Q4 2025, and down 47.69% year-over-year from $65000.0 in Q1 2025.
Silence Therapeutics' Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $34000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 47.69% year-over-year to $34000.0; the TTM figure through Mar 2026 stood at $212000.0 (up 40.63% YoY), while the FY2025 annual figure was $243000.0, down 5.45% from the prior year.
- Amortizatization of Intangibles came in at $34000.0 for Q1 2026 at Silence Therapeutics, down from $36000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $75000.0 in Q3 2025 to a low of $1178.5 in Q3 2022.
- A 5-year average of $29769.7 and a median of $15424.2 in 2023 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles slumped 80.54% in 2022 and surged 1349.37% in 2023, its largest moves.
- Silence Therapeutics' Amortizatization of Intangibles stood at $1178.5 in 2022, then jumped by 847.81% to $11170.4 in 2023, then jumped by 472.94% to $64000.0 in 2024, then plunged by 43.75% to $36000.0 in 2025, then slipped by 5.56% to $34000.0 in 2026.
- According to Business Quant data, Amortizatization of Intangibles over the past three periods registered $34000.0, $36000.0, and $75000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 13,267.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | 34,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34,000.00 |
| Mar 31, 2026 | 34,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Dec 31, 2025 | 36,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Sep 30, 2025 | 75,000.00 |
| Jun 30, 2025 | 67,000.00 |
| Jun 30, 2025 | 67,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Mar 31, 2025 | 65,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Dec 31, 2024 | 64,000.00 |
| Sep 30, 2024 | 10,394.40 |
| Sep 30, 2024 | 10,394.40 |
| Jun 30, 2024 | 11,359.99 |
| Jun 30, 2024 | 11,359.99 |
| Mar 31, 2024 | 64,000.00 |
| Mar 31, 2024 | 64,000.00 |
| Dec 31, 2023 | 11,170.37 |
| Dec 31, 2023 | 11,170.37 |
| Sep 30, 2023 | 11,400.16 |
| Sep 30, 2023 | 11,400.16 |
| Jun 30, 2023 | 2,502.73 |
| Jun 30, 2023 | 2,502.73 |
| Mar 31, 2023 | 19,448.15 |
| Mar 31, 2023 | 19,448.15 |
| Sep 30, 2022 | 1,178.55 |
| Sep 30, 2022 | 1,178.55 |
| Jun 30, 2022 | 2,518.63 |
| Jun 30, 2022 | 2,518.63 |
| Mar 31, 2022 | 1,341.84 |
| Mar 31, 2022 | 1,341.84 |
| Dec 31, 2021 | 2,696.02 |
| Dec 31, 2021 | 2,696.02 |
| Sep 30, 2021 | 5,514.33 |
| Sep 30, 2021 | 5,514.33 |
| Jun 30, 2021 | 6,988.64 |
| Jun 30, 2021 | 6,988.64 |
| Mar 31, 2021 | 6,894.60 |
| Mar 31, 2021 | 6,894.60 |
| Dec 31, 2020 | 6,602.26 |
| Dec 31, 2020 | 6,602.26 |
| Sep 30, 2020 | 6,452.51 |
| Sep 30, 2020 | 6,452.51 |